Resource Library

Download the “Decentralized Clinical Trial Products PEAK Matrix®” assessment by Everest Group to learn why Castor is a ‘Major Contendor’ provider of decentralized clinical trial products.

eConsent is imperative for continuing research during the COVID-19 pandemic and beyond, but regulations can vary widely across borders. Download this whitepaper to learn the regulatory stances of 12 countries on the use of eSignature and eConsent in clinical trials.

Castor’s new eConsent platform will improve remote patient recruitment and enrollment as well as access to diverse populations by decentralizing clinical trials.

Castor is using video conferencing to meet participant needs and lower site burden in clinical trials. Find 5 benefits here.

If you are planning on using eConsent in a trial, you’ll need to include it in your IRB submission. Find out what to include here.

Castor, a leading provider of clinical trial software, announced today the closing of a $45 million Series B financing round with Eight Roads Ventures and F-Prime Capital, bringing the company’s total funding to $65 million.

Informed consent is a critical aspect of clinical trials. But what criteria must be met? And is there more than one type of consent? Find out here.

Castor’s Action Hours during Pride Month gave all Castorians the opportunity to educate themselves and celebrate the LGBTQIA+ culture.

The future of informed consent is digital. Learn about the benefits, the process, the regulatory landscape, and the future of eConsent here.

Lightship and Castor, leading providers of decentralized clinical trial solutions, today announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale.